120 related articles for article (PubMed ID: 8273362)
1. [Interferon--a new therapeutic principle].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):408-12. PubMed ID: 8273362
[TBL] [Abstract][Full Text] [Related]
2. [Current status of interferon therapy].
Dittrich C
Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons.
Pfeffer LM; Dinarello CA; Herberman RB; Williams BR; Borden EC; Bordens R; Walter MR; Nagabhushan TL; Trotta PP; Pestka S
Cancer Res; 1998 Jun; 58(12):2489-99. PubMed ID: 9635566
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of biological activity of interferons.
Battistini A; Affabris E; Fiorucci G; Coccia EM; Romeo G; Marziali G; Rossi GB
Ann Ist Super Sanita; 1990; 26(3-4):227-53. PubMed ID: 1708952
[TBL] [Abstract][Full Text] [Related]
5. [The interferon system. A review of biological principles and clinical uses].
Schneider FJ
Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
[TBL] [Abstract][Full Text] [Related]
6. [Interferons--biologic principles and clinical uses].
Jacobsen H; Kirchner H
Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
[TBL] [Abstract][Full Text] [Related]
7. [Interferons, a class of cytokines with a large therapeutic activity range].
Billard C
Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use.
Ferrantini M; Capone I; Belardelli F
Biochimie; 2007; 89(6-7):884-93. PubMed ID: 17532550
[TBL] [Abstract][Full Text] [Related]
9. [New aspects of interferon therapy in malignant diseases].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):454-7. PubMed ID: 7505990
[TBL] [Abstract][Full Text] [Related]
10. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
11. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
12. Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha.
Cinatl J; Kotchetkov R; Blaheta R; Driever PH; Vogel JU; Cinatl J
Int J Oncol; 2002 Jan; 20(1):97-106. PubMed ID: 11743648
[TBL] [Abstract][Full Text] [Related]
13. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
14. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
16. Directed evolution of gene-shuffled IFN-alpha molecules with activity profiles tailored for treatment of chronic viral diseases.
Brideau-Andersen AD; Huang X; Sun SC; Chen TT; Stark D; Sas IJ; Zadik L; Dawes GN; Guptill DR; McCord R; Govindarajan S; Roy A; Yang S; Gao J; Chen YH; Skartved NJ; Pedersen AK; Lin D; Locher CP; Rebbapragada I; Jensen AD; Bass SH; Nissen TL; Viswanathan S; Foster GR; Symons JA; Patten PA
Proc Natl Acad Sci U S A; 2007 May; 104(20):8269-74. PubMed ID: 17494769
[TBL] [Abstract][Full Text] [Related]
17. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
18. Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.
Borden EC
Oncologist; 1998; 3(3):198-203. PubMed ID: 10388104
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of type I IFNs on the growth of WC1- CD8+ gamma delta T cells and WC1+ CD8- gamma delta T cells in vitro.
Tuo W; Bazer FW; Davis WC; Zhu D; Brown WC
J Immunol; 1999 Jan; 162(1):245-53. PubMed ID: 9886392
[TBL] [Abstract][Full Text] [Related]
20. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines.
Chawla-Sarkar M; Leaman DW; Borden EC
Clin Cancer Res; 2001 Jun; 7(6):1821-31. PubMed ID: 11410525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
